|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product revenue | |||||
| Royalties | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Total cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Goodwill impairment charges | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Total other income (expense), net | |||||
| Loss before income taxes | |||||
| Provision for (benefit from) income tax | |||||
| Net loss | |||||
| Other comprehensive income (loss) | |||||
| Changes in unrealized (loss) gain on available for sale securities | |||||
| Foreign currency translation adjustments | |||||
| Total comprehensive loss | |||||
| Net loss per common share, basic (in dollars per share) | |||||
| Net loss per common share, diluted (in dollars per share) | |||||
| Weighted-average shares used to compute basic net loss per share (in shares) | |||||
| Weighted-average shares used to compute diluted net loss per share (in shares) | |||||
Loading...